DK3650024T3 - Farmaceutisk sammensætning til nasal indgivelse omfattende rifampiciner til behandling af demens - Google Patents
Farmaceutisk sammensætning til nasal indgivelse omfattende rifampiciner til behandling af demens Download PDFInfo
- Publication number
- DK3650024T3 DK3650024T3 DK18828851.8T DK18828851T DK3650024T3 DK 3650024 T3 DK3650024 T3 DK 3650024T3 DK 18828851 T DK18828851 T DK 18828851T DK 3650024 T3 DK3650024 T3 DK 3650024T3
- Authority
- DK
- Denmark
- Prior art keywords
- rifampicins
- dementia
- treatment
- pharmaceutical composition
- nasal administration
- Prior art date
Links
- 206010012289 Dementia Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2017132955 | 2017-07-06 | ||
| PCT/JP2018/025512 WO2019009359A1 (ja) | 2017-07-06 | 2018-07-05 | 経鼻投与用医薬組成物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3650024T3 true DK3650024T3 (da) | 2023-12-04 |
Family
ID=64951007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18828851.8T DK3650024T3 (da) | 2017-07-06 | 2018-07-05 | Farmaceutisk sammensætning til nasal indgivelse omfattende rifampiciner til behandling af demens |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US11583494B2 (da) |
| EP (1) | EP3650024B1 (da) |
| JP (1) | JP7146281B2 (da) |
| CN (1) | CN110831598A (da) |
| CA (1) | CA3068690A1 (da) |
| DK (1) | DK3650024T3 (da) |
| ES (1) | ES2970909T3 (da) |
| FI (1) | FI3650024T3 (da) |
| HU (1) | HUE065421T2 (da) |
| MX (1) | MX2020000144A (da) |
| PL (1) | PL3650024T3 (da) |
| PT (1) | PT3650024T (da) |
| WO (1) | WO2019009359A1 (da) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102051624B1 (ko) * | 2018-11-30 | 2019-12-02 | 아밀로이드솔루션 주식회사 | 트리플루프로마진 또는 이의 약학적으로 허용가능한 염을 유효성분으로 포함하는 퇴행성 뇌질환 치료용 약학 조성물 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1995011248A1 (en) * | 1993-10-20 | 1995-04-27 | Teijin Limited | AMYLOID β-PROTEIN AGGLUTINATION AND/OR DEPOSITION INHIBITOR |
-
2018
- 2018-07-05 JP JP2019527959A patent/JP7146281B2/ja active Active
- 2018-07-05 PT PT188288518T patent/PT3650024T/pt unknown
- 2018-07-05 EP EP18828851.8A patent/EP3650024B1/en active Active
- 2018-07-05 MX MX2020000144A patent/MX2020000144A/es unknown
- 2018-07-05 ES ES18828851T patent/ES2970909T3/es active Active
- 2018-07-05 WO PCT/JP2018/025512 patent/WO2019009359A1/ja active Search and Examination
- 2018-07-05 CA CA3068690A patent/CA3068690A1/en active Pending
- 2018-07-05 PL PL18828851.8T patent/PL3650024T3/pl unknown
- 2018-07-05 DK DK18828851.8T patent/DK3650024T3/da active
- 2018-07-05 US US16/628,476 patent/US11583494B2/en active Active
- 2018-07-05 HU HUE18828851A patent/HUE065421T2/hu unknown
- 2018-07-05 CN CN201880044459.8A patent/CN110831598A/zh active Pending
- 2018-07-05 FI FIEP18828851.8T patent/FI3650024T3/fi active
Also Published As
| Publication number | Publication date |
|---|---|
| FI3650024T3 (fi) | 2023-12-12 |
| ES2970909T3 (es) | 2024-05-31 |
| JPWO2019009359A1 (ja) | 2020-07-27 |
| EP3650024A1 (en) | 2020-05-13 |
| US20200129426A1 (en) | 2020-04-30 |
| CA3068690A1 (en) | 2019-01-10 |
| WO2019009359A1 (ja) | 2019-01-10 |
| PL3650024T3 (pl) | 2024-03-18 |
| MX2020000144A (es) | 2020-07-22 |
| PT3650024T (pt) | 2023-12-14 |
| US11583494B2 (en) | 2023-02-21 |
| EP3650024A4 (en) | 2021-04-07 |
| CN110831598A (zh) | 2020-02-21 |
| JP7146281B2 (ja) | 2022-10-04 |
| HUE065421T2 (hu) | 2024-05-28 |
| EP3650024B1 (en) | 2023-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3717471T3 (da) | Nye forbindelser og lægemiddelsammensætninger heraf til behandling af sygdomme | |
| DK3383363T3 (da) | Topiske farmaceutiske formuleringer til behandling af inflammatorisk-relaterede tilstande | |
| DK3889145T3 (da) | 8-cyano-5-piperidino-quinoliner som TLR7/8-antagonister og anvendelser deraf til behandling af immunsygdomme | |
| DK3785733T3 (da) | Farmaceutisk sammensætning til behandling af autisme | |
| DK3349758T3 (da) | Fremgangsmåder til behandling af arenaviridae-virusinfektioner | |
| DK3402499T3 (da) | Sammensætninger og fremgangsmåder til behandlingen af type 1 diabetes | |
| DK3326641T3 (da) | Rna-holdig sammensætning til behandling af tumorsygdomme | |
| GB201720163D0 (en) | Novel compounds and pharmaceutical compositions thereof for the treatment of hepatitis B | |
| DK3357491T3 (da) | Farmaceutisk sammensætning til afgivelse af et anionisk medikament | |
| DK3253382T3 (da) | Farmaceutiske sammensætninger til kombinationsterapi | |
| DK3102213T3 (da) | Farmaceutiske sammensætninger til behandlingen af inflammatoriske lidelser | |
| DK3237045T3 (da) | Indretning til indgivelse af lægemidler | |
| DK3362066T3 (da) | Kombinationsterapi til behandling af maligniteter | |
| DK3116491T3 (da) | Farmaceutiske sammensætninger af terapeutisk aktive forbindelser | |
| DK3378482T3 (da) | Formulering til administration af antitumorlægemiddel | |
| DK3468532T3 (da) | Dispenseranordning og farmaceutisk sammensætning til behandling af rhinitis | |
| DK3258919T3 (da) | Næsepulverformulering til behandling af hypoglykæmi | |
| DK3294283T3 (da) | Sacubitril-valsartan-doseringsregime til behandling af hjerteinsufficiens | |
| DK3468604T3 (da) | Farmaceutiske kombinationer til behandling af cancer | |
| DK3328864T3 (da) | Terapeutiske forbindelser og sammensætninger til behandling af sociale forstyrrelser og stofmisbrugsforstyrrelser | |
| DK3430143T3 (da) | Inhibitorer af SRSF1 til behandlingen af neurodegenerative sygdomme | |
| DK3403674T3 (da) | Farmaceutiske sammensætninger til behandling af smerte | |
| DK3578562T3 (da) | L-valinatamidbenzoxaborolderivater til behandling af parasitiske sygdomme | |
| DK2964185T3 (da) | Præparater til behandlingen af søvnrelaterede luftvejslidelser | |
| DK3377500T3 (da) | Oxadiazaspiro-forbindelser til behandling af stofmisbrug og -afhængighed |